Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2024	Mar. 31, 2023
Current assets:
Cash and cash equivalents	$ 1,309	$ 1,498
Accounts receivable, net
Inventories	2,515	2,729
Prepaid expenses and other current assets	152	178
Fair value of derivative instruments	45	145
Assets held for sale	1	3
Total current assets	5,943	6,460
Property, plant and equipment, net	5,741	4,900
Goodwill	1,074	1,076
Intangible assets, net	545	589
Investment in and advances to non–consolidated affiliates	905	877
Deferred income tax assets	143	166
Other long–term assets
Total assets	14,628	14,364
Current liabilities:
Current portion of long–term debt	33	88
Short–term borrowings	759	671
Accounts payable
Fair value of derivative instruments	144	130
Accrued expenses and other current liabilities	627	633
Total current liabilities	4,835	4,899
Long–term debt, net of current portion	4,866	4,881
Deferred income tax liabilities	253	288
Accrued postretirement benefits	559	554
Other long–term liabilities	305	288
Total liabilities	10,818	10,910
Commitments and contingencies
Shareholder's equity:
Common stock, no par value; Unlimited number of shares authorized; 1,100 shares issued and outstanding as of March 31, 2024 and March 31, 2023	0	0
Additional paid–in capital	1,108	1,208
Retained earnings	3,072	2,472
Accumulated other comprehensive loss	(381)	(238)
Total equity of our common shareholder	3,799	3,442
Noncontrolling interests	11	12
Total equity	3,810	3,454
Total liabilities and equity	14,628	14,364
Third Parties
Accounts receivable, net
Accounts receivable, net	1,760	1,751
Other long–term assets
Other long–term assets	274	293
Accounts payable
Accounts payable	2,992	3,100
Related Parties
Accounts receivable, net
Accounts receivable, net	161	156
Other long–term assets
Other long–term assets	3	3
Accounts payable
Accounts payable	$ 280	$ 277